Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergi Papiol

Showing results (21-30 of 160) with videos related to

Pageof 16
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 19, 2003
Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disordersAraceli Rosa, Victor Peralta, Sergi Papiol, et al.
The Lancet. Psychiatry|September 12, 2015
Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based studyBeata Stepniak, Sergi Papiol, Christian Hammer, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 4, 2024
Cell type-specific polygenic burden modulates exercise effects in schizophrenia patients: further evidence on volumes of hippocampal subfieldsSergi Papiol, Lukas Roell, Isabel Maurus, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 8, 2018
Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patientsSophie K Kirchner, Selen Ozkan, Richard Musil, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 5, 2024
Sex-specific association between schizophrenia polygenic risk and subclinical schizophrenia-related traitsPatricia Mas-Bermejo, Sergi Papiol, Pilar Torrecilla, et al.
Scientific Reports|December 6, 2018
Pathway sensor-based functional genomics screening identifies modulators of neuronal activityAlexander Herholt, Ben Brankatschk, Nirmal Kannaiyan, et al.
Schizophrenia Bulletin|April 20, 2021
The Interplay Between Postsynaptic Striatal D2/3 Receptor Availability, Adversity Exposure and Odd Beliefs: A [11C]-Raclopride PET StudyLukasz Smigielski, Diana Wotruba, Valerie Treyer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 29, 2006
An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognitionCécile Henquet, Araceli Rosa, Lydia Krabbendam, et al.
Brain Imaging and Behavior|July 27, 2015
Variations in Disrupted-in-Schizophrenia 1 gene modulate long-term longitudinal differences in cortical thickness in patients with a first-episode of psychosisJavier Vázquez-Bourgon, Roberto Roiz-Santiañez, Sergi Papiol, et al.
JAMA Psychiatry|April 4, 2019
Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic TreatmentJakub Tomasik, Santiago G Lago, Javier Vázquez-Bourgon, et al.
Pageof 16

Showing results (21-30 of 160) with videos related to

Sort By:
Pageof 16
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 19, 2003
Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disordersAraceli Rosa, Victor Peralta, Sergi Papiol, et al.
The Lancet. Psychiatry|September 12, 2015
Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based studyBeata Stepniak, Sergi Papiol, Christian Hammer, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 4, 2024
Cell type-specific polygenic burden modulates exercise effects in schizophrenia patients: further evidence on volumes of hippocampal subfieldsSergi Papiol, Lukas Roell, Isabel Maurus, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 8, 2018
Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patientsSophie K Kirchner, Selen Ozkan, Richard Musil, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 5, 2024
Sex-specific association between schizophrenia polygenic risk and subclinical schizophrenia-related traitsPatricia Mas-Bermejo, Sergi Papiol, Pilar Torrecilla, et al.
Scientific Reports|December 6, 2018
Pathway sensor-based functional genomics screening identifies modulators of neuronal activityAlexander Herholt, Ben Brankatschk, Nirmal Kannaiyan, et al.
Schizophrenia Bulletin|April 20, 2021
The Interplay Between Postsynaptic Striatal D2/3 Receptor Availability, Adversity Exposure and Odd Beliefs: A [11C]-Raclopride PET StudyLukasz Smigielski, Diana Wotruba, Valerie Treyer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 29, 2006
An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognitionCécile Henquet, Araceli Rosa, Lydia Krabbendam, et al.
Brain Imaging and Behavior|July 27, 2015
Variations in Disrupted-in-Schizophrenia 1 gene modulate long-term longitudinal differences in cortical thickness in patients with a first-episode of psychosisJavier Vázquez-Bourgon, Roberto Roiz-Santiañez, Sergi Papiol, et al.
JAMA Psychiatry|April 4, 2019
Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic TreatmentJakub Tomasik, Santiago G Lago, Javier Vázquez-Bourgon, et al.
Pageof 16